Microbial oxidation of milbemycin A4 at the C-25 ethyl group was performed. Milbemycin A4 was converted to 31-and 32-hydroxy derivatives by Circinella umbellata SANK44272 along with 24-and 30-hydroxy derivatives. Related compounds, 5-ketomilbemycin A4 5-oxime and 13£-fluoromilbemycin A4 were similarly converted to the hydroxylated compounds by this microorganism. Absidia cylindrospora SANK31472 converted milbemycin A4to the corresponding 32-oic acid, 24-hydroxy derivative and a few oxygenated compounds including at the C-25 ethyl group.
parasitic and pesticidal activities. Since the discovery of this unique macrolide, intensive efforts have been directed towards chemical modification mainly at the C-5 and C-13 position of milbemycins in order to improve this biological quality. Some of the 13-alkoxy derivatives of milbemycins, which were synthesized from natural milbemycins via 1 3-hydroxy or 13-iodo derivatives, were found to exhibit excellent anthelmintic properties. 4' 5) As part of our studies on the derivatization of milbemycins, a few years ago we began investigating the microbial conversion of milbemycins, and have consequently demonstrated that the C-13 position and all the methyl groups of milbemycin A4 were hydroxylated and the 14,15-double bond was epoxidated by zygomycetesor actinomycetes.6^1^However,wehave not found hydroxylated compounds at the C-25 ethyl group of milbemycin A4 (la) which would be important intermediates to synthesize new milbemycin derivatives. Merck's group recently reported hydroxylation of the sec-butyl group at the C-25 position of 22,23-dihydroavermectin B la aglycone and avermectin by two actinomycetes, Saccharopolyspora erythrea ATCC1 1635 and Amycolata qutotrophica ATCC 35203.12'13) We independently concentrated our screening studies on finding compounds which were modified at the C-25
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Microbial Conversion of Milbemycins
The spores or mycelia from the slants were used to inoculate into either 20 ml medium/100-ml Erlenmeyer flasks or 100 ml medium/500-ml Erlenmeyer flasks. The flasks were incubated at 200~220rpm on a rotary shaker for a period of 2 days at 26°C. Then the substrate (5% (w/v) in 1,4-dioxane) was added to a final concentration of 500 /xg/ml of milbemycin A4 (la) or 250 /ig/ml of 5-ketomilbemycin A4 5-oxime (2a), 13/?-fluoromilbemycin A4 (3a), 5-ketomilbemycin A4 (4a) and 13/?- Spectral Analysis IR spectra were recorded wih a Nicolet 5S x C FT-IR spectrophotometer. NMR spectra were measured at 270MHzon a JEOLJNMGX270 spectrometer. Mass spectra were measured on a JEOLJMS-D300 spectrometer.
Results and Discussion
Microbial Conversion of Milbemycin A4 by C. umbellata SANK44272
A few strains of zygomyceteswere found to convert milbemycin A4 (la) to 1 3/?-hydroxymilbemycin A4 (lb), 30-hydroxymilbemycin A4 (lc) and three other unknown compounds (Id, le, and If) on the HPLC. Circinella umbellata SANK44272 was chosen to be used in the following preparative-scale study for characterizing new converted products.
Milbemycin A4 (500mg) was added to the growing culture (ten 500-ml flasks) of Circinella umbellata SANK 44272 and the incubation was continued. 5-Ketomilbemycin A4 5-oxime (2a, 500 mg) in twenty 500-ml flasks was converted to 2c, 2d, 2e and 2f by C. umbellata SANK44272, which were, after being purified by silica gel column chromatography and preparative HPLC,determined as the corresponding 30-, 13j8-Fluoromilbemycin A4 (3a, 45 mg) in nine 100-ml Erlenmeyer flasks was similarly subjected to conversion by C. umbellata SANK44272 to give 13j8-fluoro-30-hydroxymilbemycin A4 (3c, 4.8 mg), and two unknown compounds, 3d and 3f. After purification by preparative HPLC, 3d (4.9mg) and 3f (4.6mg) were revealed as Five conversion products were detected by analytical HPLC.They were isolated from the extracts of culture broth by preparative HPLCand determined as 13j8,32-dihydroxy-5-ketomilbemycin A4 (5f, 2.7 mg), 5-epi-13/?,30-dihydroxymilbemycin A4 (6c, 1.7mg), 5-62?z-13/?,24-dihydroxymilbemycin A4 (6d, 1.4 mg), 5-epi-13/?,31-dihydroxymilbemycin A4 (6e, 4. 1 mg) and 5-epi13j8,32-dihydroxymilbemycin A4 (6f, 8.5 mg) from the analyses of MS and *H NMRspectra. The retention times are listed in Table 2 .
In conclusion, the microbial conversion of milbemycin A4 by using C. umbellata SANK44272 has enabled us to obtain 32-and 31-hydroxymilbemycin A4. These compounds will enable us in turn to synthesize new A. cylindrospora was also determined to be able to oxidize the C-31 and C-32 positions of milbemycin A4 and related compounds.
Finally, compared with milbemycins, the oxygenated compounds newly obtained in this study did not improve their biological properties. 
